Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clinical Trials Insight: 700013079

Trial Profile

Clinical Trials Insight: 700013079

Phase of Trial: Phase I

Latest Information Update: 13 Jun 2007

At a glance

  • Drugs 2-methoxyestradiol; Paclitaxel
  • Indications Advanced breast cancer
  • Focus Adverse reactions
  • Sponsors CASI Pharmaceuticals
  • Most Recent Events

    • 13 Jun 2007 Interim results have been presented.
    • 13 Jun 2007 Status changed from initiated.
    • 23 May 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top